Clinical Trial Update: A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating how to dose Hectorol capsules when converting from Zemplar injections for Secondary Hyperparathyroidism; the study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• Hectorol (doxercalciferol)
• Zemplar (Paricalcitol)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Secondary Hyperparathyroidism | Phase 4 | Status: COMPLETED